SX-576

CAS No. 1240494-14-7

SX-576( SX 576 | SX576 )

Catalog No. M10973 CAS No. 1240494-14-7

A potent, equipotent CXCR1 and CXCR2 antagonist with IC50 of 31 nM and 21 nM, respectively.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
5MG 873 Get Quote
50MG 1782 Get Quote
100MG 2250 Get Quote
200MG Get Quote Get Quote
500MG Get Quote Get Quote
1G Get Quote Get Quote

Biological Information

  • Product Name
    SX-576
  • Note
    Research use only, not for human use.
  • Brief Description
    A potent, equipotent CXCR1 and CXCR2 antagonist with IC50 of 31 nM and 21 nM, respectively.
  • Description
    A potent, equipotent CXCR1 and CXCR2 antagonist with IC50 of 31 nM and 21 nM, respectively; exhibits potent inhibition of neutrophil influx in rat model of pulmonary inflammation.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    SX 576 | SX576
  • Pathway
    GPCR/G Protein
  • Target
    Chemokine Receptor
  • Recptor
    Chemokine Receptor
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    1240494-14-7
  • Formula Weight
    466.214
  • Molecular Formula
    C20H15BF4N2O4S
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    B(C1=C(C=C(C=C1)OC(F)(F)F)CSC2=NC=C(C=C2)C(=O)NC3=CC=C(C=C3)F)(O)O
  • Chemical Name
    (2-(((5-((4-fluorophenyl)carbamoyl)pyridin-2-yl)thio)methyl)-4-(trifluoromethoxy)phenyl)boronic acid

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1. Maeda DY, et al. Bioorg Med Chem Lett. 2015 Jun 1;25(11):2280-4. 2. Schuler AD, et al. Bioorg Med Chem Lett. 2015 Sep 15;25(18):3793-7.
molnova catalog
related products
  • GSK 214096

    A potent, selective CCR5 antagonist and HIV-1 entry inhibitor.

  • SB 332235

    A potent, selective and competitive CXCR2 inhibitor that selectively inhibits CXCR2-mediated recruitment of β-arrestin-2 with pKi of 8.92.

  • CXCR2-IN-68

    CXCR2-IN-68 is a potent, selective, brain penetrant, and orally bioavailable CXCR2 antagonist with pIC50 of 9.0.